BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20580533)

  • 1. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation.
    van Nieuwkoop C; den Exter PL; Elzevier HW; den Hartigh J; van Dissel JT
    Int J Antimicrob Agents; 2010 Dec; 36(6):485-90. PubMed ID: 20580533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization.
    Huen KH; Nik-Ahd F; Chen L; Lerman S; Singer J
    J Pediatr Urol; 2019 Apr; 15(2):178.e1-178.e7. PubMed ID: 30611650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction.
    Abrams P; Hashim H; Tomson C; Macgowan A; Skews R; Warren K
    Neurourol Urodyn; 2017 Nov; 36(8):2109-2116. PubMed ID: 28503891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of intravesical Gentamicin therapy in patients with recurrent urinary tract infections caused by multidrug resistant organisms.
    Malik Z
    J Pak Med Assoc; 2024 Jan; 74(1):118-122. PubMed ID: 38219177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant Bacteria.
    Stalenhoef JE; van Nieuwkoop C; Menken PH; Bernards ST; Elzevier HW; van Dissel JT
    J Urol; 2019 Mar; 201(3):549-555. PubMed ID: 30316898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladder- a single-center retrospective observational study.
    Mouhssine M; Al Ani D; Al Shibli A; Ghatasheh G; Al Amri A; Matta H; Chedid R; Narchi H
    J Pediatr Urol; 2023 Feb; 19(1):64.e1-64.e7. PubMed ID: 36216695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical gentamicin instillation for the treatment and prevention of urinary tract infections in complex paediatric urology patients: evidence for safety and efficacy.
    Marei MM; Jackson R; Keene DJB
    J Pediatr Urol; 2021 Feb; 17(1):65.e1-65.e11. PubMed ID: 33309610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review.
    Ziadeh T; Chebel R; Labaki C; Saliba G; Helou EE
    Urologia; 2022 May; 89(2):261-267. PubMed ID: 34612750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-related urinary tract infection in patients suffering from spinal cord injuries.
    Dedeić-Ljubović A; Hukić M
    Bosn J Basic Med Sci; 2009 Feb; 9(1):2-9. PubMed ID: 19284388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of gentamicin bladder irrigations in complex urological cases.
    Defoor W; Ferguson D; Mashni S; Creelman L; Reeves D; Minevich E; Reddy P; Sheldon C
    J Urol; 2006 May; 175(5):1861-4. PubMed ID: 16600780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent catheterisation for long-term bladder management.
    Prieto J; Murphy CL; Moore KN; Fader M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD006008. PubMed ID: 25208303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical Antibiotic Administration in the Treatment of Recurrent Urinary Tract Infections: Promising Results From a Case Series.
    Chernyak S; Salamon C
    Female Pelvic Med Reconstr Surg; 2020 Feb; 26(2):152-154. PubMed ID: 31990805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [POSITION STATEMENT FOR INTERMITTENT CATHETERIZATION OF URINARY BLADDER].
    Vainrib M; Stav K; Gruenwald I; Gilon G; Aharony S; Gross M; Bluvshtein V; Kauffman Y
    Harefuah; 2018 Apr; 157(4):257-261. PubMed ID: 29688647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term bladder management by intermittent catheterisation in adults and children.
    Moore KN; Fader M; Getliffe K
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006008. PubMed ID: 17943874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review.
    Pietropaolo A; Jones P; Moors M; Birch B; Somani BK
    Curr Urol Rep; 2018 Aug; 19(10):78. PubMed ID: 30094687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological predictors of symptoms of urinary tract infection and bacteriuria in patients treated with clean intermittent catheterization: a prospective 7-year study.
    Bakke A; Malt UF
    Eur Urol; 1998; 34(1):30-6. PubMed ID: 9676411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study.
    Bakke A; Digranes A; Høisaeter PA
    Br J Urol; 1997 Jan; 79(1):85-90. PubMed ID: 9043503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UTIs in patients with neurogenic bladder.
    Jahromi MS; Mure A; Gomez CS
    Curr Urol Rep; 2014 Sep; 15(9):433. PubMed ID: 25113150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.